BRD2 and ovarian hyperstimulation syndrome: Individualized follitropin delta dosing was shown to be safer than conventional follitropin alfa in Chinese patients, as it decreased the incidence of early OHSS and/or preventive interventions whereas much lower amounts of FSH were required to reach the same triggering criteria.